Literature DB >> 23336049

Extensive rigid analogue design maps the binding conformation of potent N-benzylphenethylamine 5-HT2A serotonin receptor agonist ligands.

Jose I Juncosa1, Martin Hansen, Lisa A Bonner, Juan Pablo Cueva, Rebecca Maglathlin, John D McCorvy, Danuta Marona-Lewicka, Markus A Lill, David E Nichols.   

Abstract

Based on the structure of the superpotent 5-HT(2A) agonist 2-(4-bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine, which consists of a ring-substituted phenethylamine skeleton modified with an N-benzyl group, we designed and synthesized a small library of constrained analogues to identify the optimal arrangement of the pharmacophoric elements of the ligand. Structures consisted of diversely substituted tetrahydroisoquinolines, piperidines, and one benzazepine. Based on the structure of (S,S)-9b, which showed the highest affinity of the series, we propose an optimal binding conformation. (S,S)-9b also displayed 124-fold selectivity for the 5-HT(2A) over the 5-HT(2C) receptor, making it the most selective 5-HT(2A) receptor agonist ligand currently known.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23336049      PMCID: PMC3547484          DOI: 10.1021/cn3000668

Source DB:  PubMed          Journal:  ACS Chem Neurosci        ISSN: 1948-7193            Impact factor:   4.418


  12 in total

1.  Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.

Authors:  Michael R Braden; Jason C Parrish; John C Naylor; David E Nichols
Journal:  Mol Pharmacol       Date:  2006-09-25       Impact factor: 4.436

2.  G protein- and agonist-bound serotonin 5-HT2A receptor model activated by steered molecular dynamics simulations.

Authors:  Vignir Isberg; Thomas Balle; Tommy Sander; Flemming Steen Jørgensen; David E Gloriam
Journal:  J Chem Inf Model       Date:  2011-01-24       Impact factor: 4.956

3.  Ramosetron for preventing postoperative nausea and vomiting in women undergoing gynecological surgery.

Authors:  Y Fujii; Y Saitoh; H Tanaka; H Toyooka
Journal:  Anesth Analg       Date:  2000-02       Impact factor: 5.108

4.  Differential phospholipase C activation by phenylalkylamine serotonin 5-HT 2A receptor agonists.

Authors:  Jason C Parrish; Michael R Braden; Emily Gundy; David E Nichols
Journal:  J Neurochem       Date:  2005-11-08       Impact factor: 5.372

5.  Mapping the catechol binding site in dopamine D₁ receptors: synthesis and evaluation of two parallel series of bicyclic dopamine analogues.

Authors:  Lisa A Bonner; Uros Laban; Benjamin R Chemel; Jose I Juncosa; Markus A Lill; Val J Watts; David E Nichols
Journal:  ChemMedChem       Date:  2011-04-28       Impact factor: 3.466

Review 6.  Role of the serotonin 5-HT(2A) receptor in learning.

Authors:  John A Harvey
Journal:  Learn Mem       Date:  2003 Sep-Oct       Impact factor: 2.460

7.  Serotonin 5-hydroxytryptamine 2A receptor-coupled phospholipase C and phospholipase A2 signaling pathways have different receptor reserves.

Authors:  Deborah M Kurrasch-Orbaugh; Val J Watts; Eric L Barker; David E Nichols
Journal:  J Pharmacol Exp Ther       Date:  2003-01       Impact factor: 4.030

8.  Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.

Authors:  A M Johansson; L E Arvidsson; U Hacksell; J L Nilsson; K Svensson; A Carlsson
Journal:  J Med Chem       Date:  1987-04       Impact factor: 7.446

9.  Dopamine D4 receptor involvement in the discriminative stimulus effects in rats of LSD, but not the phenethylamine hallucinogen DOI.

Authors:  Danuta Marona-Lewicka; Benjamin R Chemel; David E Nichols
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

10.  A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.

Authors:  C Mellin; J Vallgårda; D L Nelson; L Björk; H Yu; N E Andén; I Csöregh; L E Arvidsson; U Hacksell
Journal:  J Med Chem       Date:  1991-02       Impact factor: 7.446

View more
  13 in total

1.  Celebrating serotonin.

Authors:  Anne M Andrews
Journal:  ACS Chem Neurosci       Date:  2012-09-19       Impact factor: 4.418

2.  Lithium Enolates Derived from Weinreb Amides: Insights into Five-Membered Chelate Rings.

Authors:  Michael J Houghton; David B Collum
Journal:  J Org Chem       Date:  2016-10-17       Impact factor: 4.354

3.  Locomotor and discriminative stimulus effects of four novel hallucinogens in rodents.

Authors:  Michael B Gatch; Sean B Dolan; Michael J Forster
Journal:  Behav Pharmacol       Date:  2017-08       Impact factor: 2.293

4.  Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.

Authors:  Martin Hansen; Karina Phonekeo; James S Paine; Sebastian Leth-Petersen; Mikael Begtrup; Hans Bräuner-Osborne; Jesper L Kristensen
Journal:  ACS Chem Neurosci       Date:  2014-01-15       Impact factor: 4.418

Review 5.  Recent advances in the neuropsychopharmacology of serotonergic hallucinogens.

Authors:  Adam L Halberstadt
Journal:  Behav Brain Res       Date:  2014-07-15       Impact factor: 3.332

6.  Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability.

Authors:  Sebastian Leth-Petersen; Christoffer Bundgaard; Martin Hansen; Martin A Carnerup; Jan Kehler; Jesper Langgaard Kristensen
Journal:  Neurochem Res       Date:  2014-02-12       Impact factor: 3.996

7.  Hallucinogen-like effects of 2-([2-(4-cyano-2,5-dimethoxyphenyl) ethylamino]methyl)phenol (25CN-NBOH), a novel N-benzylphenethylamine with 100-fold selectivity for 5-HT₂A receptors, in mice.

Authors:  William E Fantegrossi; Bradley W Gray; Jessica M Bailey; Douglas A Smith; Martin Hansen; Jesper L Kristensen
Journal:  Psychopharmacology (Berl)       Date:  2014-09-17       Impact factor: 4.530

8.  Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species.

Authors:  Adam L Halberstadt; Muhammad Chatha; Adam K Klein; Jason Wallach; Simon D Brandt
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.273

9.  N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.

Authors:  David E Nichols; M Flori Sassano; Adam L Halberstadt; Landon M Klein; Simon D Brandt; Simon P Elliott; Wolfgang J Fiedler
Journal:  ACS Chem Neurosci       Date:  2015-01-21       Impact factor: 4.418

10.  5-HT2 receptor binding, functional activity and selectivity in N-benzyltryptamines.

Authors:  Miguel Toro-Sazo; José Brea; María I Loza; Marta Cimadevila; Bruce K Cassels
Journal:  PLoS One       Date:  2019-01-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.